Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions | Zendy

Jonathon Leipsic | Zendy; Jeroen J. Bax | Zendy; John G. Webb | Zendy; Randolph P. Martin | Zendy; Philipp Blanke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions

Author(s) -

Jonathon Leipsic,

Jeroen J. Bax,

John G. Webb,

Randolph P. Martin,

Philipp Blanke

Publication year - 2017

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2016.09.031

Subject(s) - valvular heart disease , medicine , stenosis , heart valve , valve replacement , randomized controlled trial , cardiology , psychological intervention , disease , intensive care medicine , aortic valve stenosis , heart disease , psychiatry

The role of imaging in the diagnosis of valvular heart disease is well established through years of investigation and validation. However, the role of imaging in guiding the treatment decision-making for valvular heart disease is less well established, and there is a striking paucity of randomized trial data to help inform these decisions. Given this relative absence of randomized trial data, the present article highlights some of the most important knowledge gaps and defines meaningful opportunities for the field to help advance the care of patients with valvular heart disease in a cost-effective fashion. (The PARTNER 3-Trial: The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis [P3]; NCT02675114; Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT02701283).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research